BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18583340)

  • 1. Connective tissue growth factor enhances osteoblastogenesis in vitro.
    Smerdel-Ramoya A; Zanotti S; Deregowski V; Canalis E
    J Biol Chem; 2008 Aug; 283(33):22690-9. PubMed ID: 18583340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia.
    Rydziel S; Stadmeyer L; Zanotti S; Durant D; Smerdel-Ramoya A; Canalis E
    J Biol Chem; 2007 Jul; 282(27):19762-72. PubMed ID: 17500060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia.
    Smerdel-Ramoya A; Zanotti S; Stadmeyer L; Durant D; Canalis E
    Endocrinology; 2008 Sep; 149(9):4374-81. PubMed ID: 18535099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connective tissue growth factor (CTGF) transactivates nuclear factor of activated T-cells (NFAT) in cells of the osteoblastic lineage.
    Smerdel-Ramoya A; Zanotti S; Canalis E
    J Cell Biochem; 2010 May; 110(2):477-83. PubMed ID: 20235153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connective tissue growth factor is a target of notch signaling in cells of the osteoblastic lineage.
    Canalis E; Zanotti S; Smerdel-Ramoya A
    Bone; 2014 Jul; 64():273-80. PubMed ID: 24792956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells.
    Luo Q; Kang Q; Si W; Jiang W; Park JK; Peng Y; Li X; Luu HH; Luo J; Montag AG; Haydon RC; He TC
    J Biol Chem; 2004 Dec; 279(53):55958-68. PubMed ID: 15496414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro.
    Nishida T; Nakanishi T; Asano M; Shimo T; Takigawa M
    J Cell Physiol; 2000 Aug; 184(2):197-206. PubMed ID: 10867644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling.
    Deregowski V; Gazzerro E; Priest L; Rydziel S; Canalis E
    J Biol Chem; 2006 Mar; 281(10):6203-10. PubMed ID: 16407293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regeneration of defects in articular cartilage in rat knee joints by CCN2 (connective tissue growth factor).
    Nishida T; Kubota S; Kojima S; Kuboki T; Nakao K; Kushibiki T; Tabata Y; Takigawa M
    J Bone Miner Res; 2004 Aug; 19(8):1308-19. PubMed ID: 15231019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephroblastoma overexpressed (Nov) is a novel bone morphogenetic protein antagonist.
    Canalis E
    Ann N Y Acad Sci; 2007 Nov; 1116():50-8. PubMed ID: 18083920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enamel matrix derivative induces connective tissue growth factor expression in human osteoblastic cells.
    Heng NH; N'Guessan PD; Kleber BM; Bernimoulin JP; Pischon N
    J Periodontol; 2007 Dec; 78(12):2369-79. PubMed ID: 18052711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and regulation of CCN genes in murine osteoblasts.
    Parisi MS; Gazzerro E; Rydziel S; Canalis E
    Bone; 2006 May; 38(5):671-7. PubMed ID: 16311085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization.
    Crean JK; Furlong F; Finlay D; Mitchell D; Murphy M; Conway B; Brady HR; Godson C; Martin F
    FASEB J; 2004 Oct; 18(13):1541-3. PubMed ID: 15319369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the TGFbeta/Smad signaling pathway in mesangial cells by CTGF/CCN2.
    Wahab NA; Weston BS; Mason RM
    Exp Cell Res; 2005 Jul; 307(2):305-14. PubMed ID: 15950619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression.
    Pereira RC; Delany AM; Canalis E
    Bone; 2002 May; 30(5):685-91. PubMed ID: 11996905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the RAM domain and ankyrin repeats on notch signaling and activity in cells of osteoblastic lineage.
    Deregowski V; Gazzerro E; Priest L; Rydziel S; Canalis E
    J Bone Miner Res; 2006 Aug; 21(8):1317-26. PubMed ID: 16869730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch 1 impairs osteoblastic cell differentiation.
    Sciaudone M; Gazzerro E; Priest L; Delany AM; Canalis E
    Endocrinology; 2003 Dec; 144(12):5631-9. PubMed ID: 12960086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of twisted gastrulation inhibits bone morphogenetic protein action and prevents osteoblast cell differentiation in vitro.
    Gazzerro E; Deregowski V; Vaira S; Canalis E
    Endocrinology; 2005 Sep; 146(9):3875-82. PubMed ID: 15919755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue growth factor increases matrix metalloproteinase-2 and suppresses tissue inhibitor of matrix metalloproteinase-2 production by cultured renal interstitial fibroblasts.
    Yang M; Huang H; Li J; Huang W; Wang H
    Wound Repair Regen; 2007; 15(6):817-24. PubMed ID: 18028129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of BMP-induced transcription in cultured human bone marrow stromal cells.
    Diefenderfer DL; Osyczka AM; Garino JP; Leboy PS
    J Bone Joint Surg Am; 2003; 85-A Suppl 3():19-28. PubMed ID: 12925605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.